• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Flt3激活通过在心脏重塑过程中阻碍乙酰化p53与PHB2之间的相互作用,重新平衡L-OPA1加工过程,减轻线粒体碎片化和心脏功能障碍。

Flt3 Activation Mitigates Mitochondrial Fragmentation and Heart Dysfunction through Rebalanced L-OPA1 Processing by Hindering the Interaction between Acetylated p53 and PHB2 in Cardiac Remodeling.

作者信息

Zhang Kaina, Zheng Yeqing, Bao Gaowa, Ma Wenzhuo, Han Bing, Shi Hongwen, Zhao Zhenghang

机构信息

Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.

Institute of Cardiovascular Sciences, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.

出版信息

Antioxidants (Basel). 2023 Aug 22;12(9):1657. doi: 10.3390/antiox12091657.

DOI:10.3390/antiox12091657
PMID:37759959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10525215/
Abstract

Recent studies have shown that FMS-like receptor tyrosine kinase 3 (Flt3) has a beneficial effect on cardiac maladaptive remodeling. However, the role and mechanism of Flt3 in mitochondrial dynamic imbalance under cardiac stress remains poorly understood. This study aims to investigate how Flt3 regulates p53-mediated optic atrophy 1 (OPA1) processing and mitochondrial fragmentation to improve cardiac remodeling. Mitochondrial fragmentation in cardiomyocytes was induced by isoprenaline (ISO) and HO challenge, respectively, in vitro. Cardiac remodeling in mice was established by ligating the left anterior descending coronary artery or by chronic ISO challenge, respectively, in vivo. Our results demonstrated that the protein expression of acetylated-p53 (ac-p53) in mitochondria was significantly increased under cell stress conditions, facilitating the dissociation of PHB2-OPA1 complex by binding to prohibitin 2 (PHB2), a molecular chaperone that stabilizes OPA1 in mitochondria. This led to the degradation of the long isoform of OPA1 (L-OPA1) that facilitates mitochondrial fusion and resultant mitochondrial network fragmentation. This effect was abolished by a p53 K371R mutant that failed to bind to PHB2 and impeded the formation of the ac-p53-PHB2 complex. The activation of Flt3 significantly reduced ac-p53 expression in mitochondria via SIRT1, thereby hindering the formation of the ac-p53-PHB2 complex and potentiating the stability of the PHB2-OPA1 complex. This ultimately inhibits L-OPA1 processing and leads to the balancing of mitochondrial dynamics. These findings highlight a novel mechanism by which Flt3 activation mitigates mitochondrial fragmentation and dysfunction through the reduction of L-OPA1 processing by dampening the interaction between ac-p53 and PHB2 in cardiac maladaptive remodeling.

摘要

最近的研究表明,FMS样受体酪氨酸激酶3(Flt3)对心脏适应性不良重塑具有有益作用。然而,Flt3在心脏应激下线粒体动态失衡中的作用和机制仍知之甚少。本研究旨在探讨Flt3如何调节p53介导的视神经萎缩蛋白1(OPA1)加工和线粒体分裂以改善心脏重塑。在体外,分别用异丙肾上腺素(ISO)和HO刺激诱导心肌细胞中的线粒体分裂。在体内,分别通过结扎左冠状动脉前降支或慢性ISO刺激建立小鼠心脏重塑模型。我们的结果表明,在细胞应激条件下,线粒体中乙酰化p53(ac-p53)的蛋白表达显著增加,通过与禁止素2(PHB2)结合促进PHB2-OPA1复合物的解离,PHB2是一种在线粒体中稳定OPA1的分子伴侣。这导致促进线粒体融合的OPA1长异构体(L-OPA1)降解,从而导致线粒体网络碎片化。这种作用被未能与PHB2结合并阻碍ac-p53-PHB2复合物形成的p53 K371R突变体所消除。Flt3的激活通过SIRT1显著降低线粒体中ac-p53的表达,从而阻碍ac-p53-PHB2复合物的形成并增强PHB2-OPA1复合物的稳定性。这最终抑制L-OPA1加工并导致线粒体动力学平衡。这些发现突出了一种新机制,即Flt3激活通过减少心脏适应性不良重塑中ac-p53与PHB2之间的相互作用来减轻线粒体碎片化和功能障碍,从而减少L-OPA1加工。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/6d0c08c5ed71/antioxidants-12-01657-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/9060f25c6d9f/antioxidants-12-01657-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/13acc556decf/antioxidants-12-01657-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/260e0c4e5c78/antioxidants-12-01657-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/d4e78ff44ab9/antioxidants-12-01657-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/94ee944f010a/antioxidants-12-01657-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/5d88a3813fea/antioxidants-12-01657-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/55b86d5d5c70/antioxidants-12-01657-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/8e564f128af1/antioxidants-12-01657-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/ca137c5b5cb2/antioxidants-12-01657-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/c6b64178f5a5/antioxidants-12-01657-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/6d0c08c5ed71/antioxidants-12-01657-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/9060f25c6d9f/antioxidants-12-01657-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/13acc556decf/antioxidants-12-01657-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/260e0c4e5c78/antioxidants-12-01657-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/d4e78ff44ab9/antioxidants-12-01657-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/94ee944f010a/antioxidants-12-01657-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/5d88a3813fea/antioxidants-12-01657-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/55b86d5d5c70/antioxidants-12-01657-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/8e564f128af1/antioxidants-12-01657-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/ca137c5b5cb2/antioxidants-12-01657-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/c6b64178f5a5/antioxidants-12-01657-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b34/10525215/6d0c08c5ed71/antioxidants-12-01657-g011.jpg

相似文献

1
Flt3 Activation Mitigates Mitochondrial Fragmentation and Heart Dysfunction through Rebalanced L-OPA1 Processing by Hindering the Interaction between Acetylated p53 and PHB2 in Cardiac Remodeling.Flt3激活通过在心脏重塑过程中阻碍乙酰化p53与PHB2之间的相互作用,重新平衡L-OPA1加工过程,减轻线粒体碎片化和心脏功能障碍。
Antioxidants (Basel). 2023 Aug 22;12(9):1657. doi: 10.3390/antiox12091657.
2
Activation of FMS-like tyrosine kinase 3 protects against isoprenaline-induced cardiac hypertrophy by improving autophagy and mitochondrial dynamics.FMS 样酪氨酸激酶 3 的激活通过改善自噬和线粒体动力学来防止异丙肾上腺素诱导的心肌肥厚。
FASEB J. 2022 Dec;36(12):e22672. doi: 10.1096/fj.202200419RR.
3
p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers.在妇科癌症中,顺铂诱导的线粒体融合蛋白L-Opa1的加工过程需要p53参与,该过程由线粒体金属肽酶Oma1介导。
J Biol Chem. 2014 Sep 26;289(39):27134-27145. doi: 10.1074/jbc.M114.594812. Epub 2014 Aug 11.
4
Mitoquinone attenuates blood-brain barrier disruption through Nrf2/PHB2/OPA1 pathway after subarachnoid hemorrhage in rats.甲萘醌通过 Nrf2/PHB2/OPA1 通路减轻大鼠蛛网膜下腔出血后血脑屏障的破坏。
Exp Neurol. 2019 Jul;317:1-9. doi: 10.1016/j.expneurol.2019.02.009. Epub 2019 Feb 16.
5
Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration.抑素膜支架的丧失会损害线粒体的结构,导致过度磷酸化的 tau 蛋白积聚和神经退行性变。
PLoS Genet. 2012;8(11):e1003021. doi: 10.1371/journal.pgen.1003021. Epub 2012 Nov 8.
6
Pyruvate kinase M2 sustains cardiac mitochondrial quality surveillance in septic cardiomyopathy by regulating prohibitin 2 abundance via S91 phosphorylation.丙酮酸激酶 M2 通过 S91 磷酸化调节抑制素 2 的丰度来维持脓毒症心肌病中心肌线粒体的质量监控。
Cell Mol Life Sci. 2024 Jun 10;81(1):254. doi: 10.1007/s00018-024-05253-9.
7
stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way.稳定肝细胞中的 OPA1 以依赖于 prohibitin 的方式增强线粒体呼吸和糖异生。
J Biol Chem. 2019 Aug 23;294(34):12581-12598. doi: 10.1074/jbc.RA119.007601. Epub 2019 Jul 8.
8
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.抑素 1 通过与 p53 相互作用调节妇科癌症中线粒体动力学和化疗耐药性。
J Ovarian Res. 2022 Jun 7;15(1):70. doi: 10.1186/s13048-022-00999-x.
9
Phosphoglycerate mutase 5 exacerbates alcoholic cardiomyopathy in male mice by inducing prohibitin-2 dephosphorylation and impairing mitochondrial quality control.磷酸甘油酸变位酶 5 通过诱导抑制素-2 去磷酸化和损害线粒体质量控制,加剧雄性小鼠的酒精性心肌病。
Clin Transl Med. 2024 Aug;14(8):e1806. doi: 10.1002/ctm2.1806.
10
PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels.多发性硬化症患者的外周血单核细胞显示OPA1加工失调,与活性氧增加和PHB2蛋白水平升高有关。
Biomedicines. 2020 Apr 11;8(4):85. doi: 10.3390/biomedicines8040085.

引用本文的文献

1
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.肺动脉高压:分子机制与临床研究
MedComm (2020). 2025 Mar 10;6(3):e70134. doi: 10.1002/mco2.70134. eCollection 2025 Mar.
2
Phosphoglycerate mutase 5 exacerbates alcoholic cardiomyopathy in male mice by inducing prohibitin-2 dephosphorylation and impairing mitochondrial quality control.磷酸甘油酸变位酶 5 通过诱导抑制素-2 去磷酸化和损害线粒体质量控制,加剧雄性小鼠的酒精性心肌病。
Clin Transl Med. 2024 Aug;14(8):e1806. doi: 10.1002/ctm2.1806.

本文引用的文献

1
PHB2 ameliorates Doxorubicin-induced cardiomyopathy through interaction with NDUFV2 and restoration of mitochondrial complex I function.PHB2 通过与 NDUFV2 相互作用和恢复线粒体复合物 I 功能来改善多柔比星诱导的心肌病。
Redox Biol. 2023 Sep;65:102812. doi: 10.1016/j.redox.2023.102812. Epub 2023 Jul 12.
2
Myocardial ischemia-reperfusion injury; Molecular mechanisms and prevention.心肌缺血再灌注损伤;分子机制与预防
Microvasc Res. 2023 Sep;149:104565. doi: 10.1016/j.mvr.2023.104565. Epub 2023 Jun 10.
3
Drp1/p53 interaction mediates p53 mitochondrial localization and dysfunction in septic cardiomyopathy.
Drp1/p53 相互作用介导脓毒症性心肌病中 p53 的线粒体定位和功能障碍。
J Mol Cell Cardiol. 2023 Apr;177:28-37. doi: 10.1016/j.yjmcc.2023.01.008. Epub 2023 Feb 24.
4
Molecular Mechanisms of Mitochondrial Quality Control in Ischemic Cardiomyopathy.缺血性心肌病中线粒体质量控制的分子机制。
Int J Biol Sci. 2023 Jan 1;19(2):426-448. doi: 10.7150/ijbs.76223. eCollection 2023.
5
Activation of FMS-like tyrosine kinase 3 protects against isoprenaline-induced cardiac hypertrophy by improving autophagy and mitochondrial dynamics.FMS 样酪氨酸激酶 3 的激活通过改善自噬和线粒体动力学来防止异丙肾上腺素诱导的心肌肥厚。
FASEB J. 2022 Dec;36(12):e22672. doi: 10.1096/fj.202200419RR.
6
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.抑素 1 通过与 p53 相互作用调节妇科癌症中线粒体动力学和化疗耐药性。
J Ovarian Res. 2022 Jun 7;15(1):70. doi: 10.1186/s13048-022-00999-x.
7
Structural and Functional Remodeling of Mitochondria in Cardiac Diseases.心脏疾病中线粒体的结构和功能重塑。
Int J Mol Sci. 2021 Apr 17;22(8):4167. doi: 10.3390/ijms22084167.
8
OMA1-An integral membrane protease?OMA1—一种整合膜蛋白酶?
Biochim Biophys Acta Proteins Proteom. 2021 Feb;1869(2):140558. doi: 10.1016/j.bbapap.2020.140558. Epub 2020 Oct 29.
9
GDF11 enhances therapeutic efficacy of mesenchymal stem cells for myocardial infarction via YME1L-mediated OPA1 processing.GDF11 通过 YME1L 介导的 OPA1 加工增强间充质干细胞治疗心肌梗死的疗效。
Stem Cells Transl Med. 2020 Oct;9(10):1257-1271. doi: 10.1002/sctm.20-0005. Epub 2020 Jun 9.
10
Activated FMS-like tyrosine kinase 3 ameliorates angiotensin II-induced cardiac remodelling.活化的FMS样酪氨酸激酶3可改善血管紧张素II诱导的心脏重塑。
Acta Physiol (Oxf). 2020 Oct;230(2):e13519. doi: 10.1111/apha.13519. Epub 2020 Jun 18.